IndraLab

Statements


| 11

reach
"Berberine, an active component of coptis chinensis, can inhibit the activation of ROS-dependent NLRP3 inflammatory bodies and reduce the synthesis of pro-IL-1β by inhibiting NF-κB, so it can be used in the prevention and treatment of atherosclerosis (Ju et al., 2018)."

reach
"Berberine suppresses influenza virus triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS."

reach
"Berberine attenuates uric acid-induced cell injury by inhibiting NLRP3 signaling pathway in HK-2 cells."

reach
"Berberine can also inhibit the activation of the NLRP3 inflammasome by upregulating the level of macrophage autophagy."

reach
"There was evidence that berberine inhibited NLRP3 inflammasome pathway in MDA-MB-231 cell (Yao et al., 2019)."

reach
"Moreover, berberine prevented influenza virus-induced NLRP3 activation by promoting mitophagy and reducing mitochondrial oxidative stress (Liu et al., 2020a)."

reach
"Berberine inhibits NLRP3 Inflammasome pathway in human triple negative breast cancer MDA-MB-231 cell."

reach
"Berberine Attenuates NLRP3 Inflammasome Activation in Macrophages to Reduce the Secretion of Interleukin-1beta."

reach
"Berberine inhibited hepatic necroinflammation, IL-1beta, and NLRP3 inflammasome in non alcoholic steatohepatitis (NASH) induced by methionine and choline - deficient diet in mouse, which based on interference with activation of P2x7, a purinergic receptor involved in inflammasome activation."

reach
"The alkaloids, berberine and ligustrazine, were found to inhibit the NLRP3 inflammasome."

reach
"Liu et al. observed that berberine inhibited NLR family pyrin domain containing 3 (NLRP3) inflammasome activation in the influenza virus as well as a decline in ROS generation (Liu et al., 2020)."